A long term experimental study of canine visceral leishmaniasis

International Journal for Parasitology

Volumn 37, Issue 6, 2007, Pages 683-693

  Rodríguez Cortés, Alhelí ^a   Ojeda, Ana ^c   López Fuertes, Laura ^b   Timón, Marcos ^b   Altet, Laura ^c   Solano Gallego, Laia ^a   Sánchez Robert, Elisenda ^c   Francino, Olga ^c   Alberola, Jordi ^a  

^a Terapeutica i Toxicologia Veterinaria   (Spain)

^b Agencia Espanola del Medicamento   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CMI; Dog; Experimental infection; IgA; IgG; IgM; Leishmania; Parasitaemia

Indexed keywords

DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M;

ANTIBODY; CANID; DNA; EXPERIMENTAL STUDY; FLAGELLATE; IMMUNE RESPONSE; IMMUNOASSAY; LEISHMANIASIS; PARASITE INFESTATION; PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG; EXPERIMENTAL INFECTION; FEMALE; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL PARAMETERS; LEISHMANIA INFANTUM; LIVER; LYMPH NODE; MONITORING; NONHUMAN; PARASITEMIA; SKIN; SPLEEN; T LYMPHOCYTE; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BONE MARROW; DNA, PROTOZOAN; DOG DISEASES; DOGS; FEMALE; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; LIVER; LYMPH NODES; SKIN; SKIN TESTS; SPLEEN; TIME FACTORS;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 33947301620     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2006.11.007     Document Type: Article

References (51)

1. Alberola J., Rodriguez A., Francino O., Roura X., Rivas L., and Andreu D. Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis. J. Antimicrob. Chemother. 48 (2004) 641-643
2. Altet L., Francino O., Solano-Gallego L., Renier C., and Sanchez A. Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs. Infect. Immun. 70 (2002) 2763-2771
3. Berrahal F., Mary C., Roze M., Berenger A., Escoffier K., Lamouroux D., and Dunan S. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am. J. Trop. Med. Hyg. 55 (1996) 273-277
4. Borja-Cabrera G., Correia Pontes N., da Silva V., Paraguai de Souza E., Santos W., Gomes E., Luz K., Palatnik M., and Palatnik de Sousa C. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Gonçalo do Amarante, RN). Vaccine 20 (2002) 3277-3284
5. Bossolasco S., Gaiera G., Olchini D., Gulletta M., Martello L., Bestetti A., Bossi L., Germagnoli L., Lazzarin A., Uberti-Foppa C., and Cinque P. Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis. J. Clin. Microbiol. 41 (2003) 5080-5084
6. Bourdoiseau G., Bonnefont C., Hoareau E., Boehringer C., Stolle T., and Chabanne L. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Vet. Immunol. Immunopathol. 59 (1997) 21-30
7. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Invest. 21 (1968) 77-89
8. Bretagne S., Durand R., Olivi M., Garin J.F., Sulahian A., Rivollet D., Vidaud M., and Deniau M. Real-time PCR as a new tool for quantifying Leishmania infantum in liver in infected mice. Clin. Diagn. Lab. Immunol. 8 (2001) 828-831
9. Cabral M., O'Grady J.E., Gomes S., Sousa J.C., Thompson H., and Alexander J. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs. Vet. Parasitol. 76 (1998) 173-180
10. Cardoso L., Neto F., Sousa J.C., Rodrigues M., and Cabral M. Use of leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet. Parasitol. 79 (1998) 213-220
11. Courtenay O., Quinnell R., Garcez L., Shaw J., and Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 186 (2002) 1314-1320
12. Deplazes P., Smith N.C., Arnold P., Lutz H., and Eckert J. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17 (1995) 451-458
13. Engwerda C.R., and Kaye P.M. Organ-specific immune responses associated with infectious disease. Immunol. Today 21 (2000) 73-78
14. Fernandez-Bellon H., Solano-Gallego L., Rodriguez A., Rutten V.P., Hoek A., Ramis A., Alberola J., and Ferrer L. Comparison of three assays for the evaluation of specific cellular immunity to Leishmania infantum in dogs. Vet. Immunol. Immunopathol. 107 (2005) 163-169
15. Fisa R., Gallego M., Castillejo S., Aisa M.J., Serra T., Riera C., Carrio J., Gallego J., and Portus M. Epidemiology of canine leishmaniosis in catalonia (Spain) the example of the priorat focus. Vet. Parasitol. 83 (1999) 87-97
16. Francino O., Altet L., Sanchez-Robert E., Rodriguez A., Solano-Gallego L., Alberola J., Ferrer L., Sanchez A., and Roura X. Advantages of real-time PCR assay for diagnosis and monitoring of canine leishmaniosis. Vet. Parasitol. 137 (2006) 214-221
17. Guarga J., Moreno J., Lucientes J., Gracia M., Peribanez M., and Castillo J. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 88 (2002) 13-20
18. Kaye P.M., Curry A.J., and Blackwell J.M. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146 (1991) 2763-2770
19. Killick-Kendrick R., Killick-Kendrick M., Pinelli E., Del Real G., Molina R., Vitutia M., Cañavate M.C., and Nieto J. A laboratory model of canine leishmaniasis: the inoculation of dogs with Leishmania infantum promastigotes from midguts of experimentally infected phlebotomine sandflies. Parasite 1 (1994) 311-318
20. Leandro C., Santos-Gomes G.M., Campino L., Romao P., Cortes S., Rolao N., Gomes-Pereira S., Riça Capela M.J., and Abranches P. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Vet. Immunol. Immunopathol. 79 (2001) 273-284
21. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
22. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
23. Martinez-Moreno A., Moreno T., Martinez-Moreno F.J., Acosta I., and Hernandez S. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48 (1995) 209-220
24. Mathis A., and Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J. Clin. Microbiol. 33 (1995) 1145-1149
25. Molano I., Alonso M., Miron C., Redondo E., Requena J., Soto M., Nieto C., and Alonso C. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Vet. Immunol. Immunopathol. 92 (2003) 1-13
26. Moreno J., and Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 18 (2002) 399-405
27. Moreno J., Nieto J., Chamizo C., Gonzalez F., Blanco F., Barker D.C., and Alva J. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy. Vet. Immunol. Immunopathol. 71 (1999) 181-195
28. Pennisi M.G., Reale S., Giudice S.L., Masucci M., Caracappa S., Vitale M., and Vitale F. Real-time PCR in dogs treated for leishmaniasis with allopurinol. Vet. Res. Commun. 29 (2005) 301-303
29. Pinelli E., Killick-Kendrick R., Wagenaar J., Bernadina W., del Real G., and Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62 (1994) 229-235
30. Pinelli E., Rutten V.P.M.G., Bruysters M., Moore P.F., and Ruitenberg E.J. Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production. Infect. Immun. 67 (1999) 237-243
31. Poot J., Rogers M.E., Bates P.A., and Vermeulen A. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Vet. Parasitol. 130 (2005) 41-53
32. Quinnell R.J., Courtenay O., Davidson S., Garcez L., Lambson B., Ramos P., Shaw J.J., Shaw M.A., and Dye C. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology 122 (2001) 253-261
33. Quinnell R.J., Kennedy L.J., Barnes A., Courtenay O., Dye C., Garcez L.M., Shaw M.A., Carter S.D., Thomson W., and Ollier W.E. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics 55 (2003) 23-28
34. Ramiro M., Zarate J., Hanke T., Rodriguez D., Rodriguez J., Esteban M., Lucientes J., Castillo J., and Larraga V. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 21 (2003) 2474-2484
35. Reis A.B., Martins-Filho O.A., Teixeira-Carvalho A., Carvalho M.G., Mayrink W., Franca-Silva J.C., Giunchetti R.C., Genaro O., and Correa-Oliveira R. Parasite density and impaired biochemical/hematological status are associated with severe clinical aspects of canine visceral leishmaniasis. Res. Vet. Sci. 81 (2005) 68-75
36. Reis A.B., Teixeira-Carvalho A., Vale A.M., Marques M.J., Giunchetti R.C., Mayrink W., Guerra L.L., Andrade R.A., Correa-Oliveira R., and Martins-Filho O.A. Isotype patterns of immunoglobulins: Hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi. Vet. Immunol. Immunopathol. 112 (2006) 102-116
37. Requena J.M., Soto M., Doria M.D., and Alonso C. Immune and clinical parameters associated with Leishmania infantum infection in the golden hamster model. Vet. Immunol. Immunopathol. 76 (2000) 269-281
38. Rhalem A., Sahibi H., Guessous-Idrissi N., Lasri S., Natami A., Riyad M., and Berrag B. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81 (1999) 173-184
39. Rica-Capela M., Cortes S., Leandro C., Peleteiro M., Santos-Gomes G., and Campino L. Immunological and histopathological studies in a rodent model infected with Leishmania infantum promastigotes or amastigotes. Parasitol. Res. 89 (2003) 163-169
40. Rodríguez A., Solano-Gallego L., Ojeda A., Quintana J., Riera C., Gállego M., Portús M., and Alberola J. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. J. Vet. Int. Med. 20 (2006) 495-498
41. Sanchez M.A., Diaz N.L., Zerpa O., Negron E., Convit J., and Tapia F.J. Organ-specific immunity in canine visceral leishmaniasis: analysis of symptomatic and asymptomatic dogs naturally infected with Leishmania chagasi. Am. J. Trop. Med. Hyg. 70 (2004) 618-624
42. Satti I., el Hassan A., Khalil el T.A., and Akuffo H. The effect of repeated leishmanin skin testing on the immune responses to Leishmania antigen in healthy volunteers. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 565-567
43. Sideris V., Papadopoulou G., Dotsika E., and Karagouni E. Asymptomatic canine leishmaniasis in Greater Athens area, Greece. Eur. J. Epidemiol. 15 (1999) 271-276
44. Slappendel R.J. Canine leishmaniasis: A review based on 95 cases in the Netherlands. Vet. Q. 10 (1988) 1-16
45. Solano-Gallego L., Llull J., Ramos G., Riera C., Arboix M., Alberola J., and Ferrer L. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Vet. Parasitol. 90 (2000) 37-45
46. Solano-Gallego L., Morell P., Arboix M., Alberola J., and Ferrer L. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J. Clin. Microbiol. 39 (2001) 560-563
47. Solano-Gallego L., Riera C., Roura X., Iniesta L., Gallego M., Valladares J.E., Fisa R., Castillejo S., Alberola J., Ferrer L., Arboix M., and Portus M. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Vet. Parasitol. 96 (2001) 265-276
48. Steuber S., Moritz A., Schirrmann I., and Greiner M. PCR follow-up examination after treatment of canine leishmaniosis (CaL). Tokai J. Exp. Clin. Med. 23 (1998) 285-292
49. Travi B.L., Tabares C.J., Cadena H., Ferro C., and Osorio Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am. J. Trop. Med. Hyg. 63 (2001) 119-124
50. Valladares J.E., Riera C., Alberola J., Gallego M., Portus M., Cristofol C., Franquelo C., and Arboix M. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Vet. Parasitol. 75 (1998) 33-40
51. Weigle K.A., Valderrama L., Arias A.L., Santrich C., and Saravia N.G. Leishmanin skin test standardization and evaluation of safety, dose, storage, longevity of reaction and sensitization. Am. J. Trop. Med. Hyg. 44 (1991) 260-271